Trevi Therapeutics, Inc. (TRVI) Capital expenditures 2018–2025
Trevi Therapeutics, Inc. (TRVI) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$12,000FY2025 · since FY2018: $158,000 → $12,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $12,000 | -65.7% |
| FY2024 | $35,000 | -74.5% |
| FY2023 | $137,000 | -13.8% |
| FY2022 | $159,000 | — |
| FY2020 | $32,000 | +255.6% |
| FY2019 | $9,000 | -94.3% |
| FY2018 | $158,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice